CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer

Jiexiao Wang,Jialiang Wang,Xiang Huang,Yanfei Zhou,Jian Qi,Xiaojun Sun,Jinfu Nie,Zongtao Hu,Shujie Wang,Bo Hong,Hongzhi Wang
DOI: https://doi.org/10.1186/s12880-024-01221-8
IF: 2.7949
2024-02-16
BMC Medical Imaging
Abstract:Tumor mutational burden (TMB) is one of the most significant predictive biomarkers of immunotherapy efficacy in non-small cell lung cancer (NSCLC). Radiomics allows high-throughput extraction and analysis of advanced and quantitative medical imaging features. This study develops and validates a radiomic model for predicting TMB level and the response to immunotherapy based on CT features in NSCLC.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?